Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    "desmoid tumor"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Toremifene in Treating Patients With Desmoid Tumors
Condition: Desmoid Tumor
Interventions: Drug: toremifene;   Procedure: conventional surgery
2 Completed Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Condition: Desmoid Tumor
Interventions: Drug: methotrexate;   Drug: vinblastine sulfate
3 Recruiting PAZOPANIB Efficacy and Tolerance in Desmoids Tumors
Condition: Progressive Desmoids Tumors
Interventions: Drug: PAZOPANIB treatment;   Drug: Active Comparator: Vinblastine and Methotrexate
4 Completed Radiation Therapy in Treating Patients With Aggressive Fibromatoses
Condition: Desmoid Tumor
Intervention: Radiation: radiation therapy
5 Active, not recruiting
Has Results
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Condition: Desmoid Tumor
Interventions: Drug: tamoxifen citrate;   Drug: sulindac;   Other: laboratory biomarker analysis
6 Recruiting Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment
Condition: Desmoid Tumors
Intervention: Device: "cryoprobes"
7 Active, not recruiting Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Conditions: Desmoid Tumors;   Aggressive Fibromatosis
Intervention: Drug: PF-03084014
8 Recruiting A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
Condition: Desmoid Tumor
Intervention: Drug: Sirolimus
9 Active, not recruiting Study to Evaluate Imatinib in Desmoid Tumors
Conditions: Aggressive Fibromatosis;   Desmoid Tumor
Intervention: Drug: Imatinib
10 Recruiting 18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Conditions: Deep Fibromatosis/Desmoid Tumor;   Familial Adenomatous Polyposis
Interventions: Radiation: F-18 16 Alpha-Fluoroestradiol;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
11 Withdrawn Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
Conditions: Desmoid Tumors;   Fibromatosis
Intervention: Drug: Hydroxyurea
12 Completed Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
Condition: Desmoid Tumor
Intervention: Drug: imatinib mesylate
13 Active, not recruiting Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
Conditions: Advanced Desmoid Tumor;   Advanced Chondrosarcoma
Intervention: Drug: Imatinib Mesylate
14 Recruiting National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)
Condition: Aggressive Fibromatosis
Interventions: Procedure: biopsy;   Other: biobank constitution;   Procedure: Coloscopy;   Procedure: Blood sampling (facultative);   Other: Pain evaluation;   Procedure: Tumor biobank realization
15 Recruiting Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
Condition: Desmoid Type-fibromatosis
Intervention: Drug: Toremifene
16 Recruiting Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
Condition: Desmoid-type Fibromatosis
Intervention: Other: Observational approach
17 Suspended Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition: Desmoid-Type Fibromatosis
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Drug: Sorafenib Tosylate
18 Recruiting Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors
Conditions: The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an;   Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After;   Surgical Resection
Intervention: Drug: 5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.
19 Completed A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome
Conditions: Gardner Syndrome;   Colorectal Carcinoma;   Desmoid Tumor
Intervention:
20 Temporarily not available Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies
Conditions: Neoplasm;   Desmoid Tumor
Intervention: Drug: PF-03084014

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.